Reduced T-bet in addition to enhanced STAT6 and GATA3 expressing T cells contribute to human allergen-induced late responses

Clinical and Experimental Allergy

Volumn 42, Issue 6, 2012, Pages 891-900

  Eifan, A O ^a   Furukido, K ^a   Dumitru, A ^a   Jacobson, M R ^a   Schmidt Weber, C ^a   Banfield, G ^a   Durham, Stephen R ^a   Nouri Aria, K T ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergic rhinitis; GATA3; Human models of Th1 and Th2; Late skin and nasal responses; Stat6; T bet; Tuberculin

Indexed keywords

ALLERGEN; DILUENT; INTERLEUKIN 4; MESSENGER RNA; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ADULT; ALLERGIC RHINITIS; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRASS POLLEN; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALE; NASAL BIOPSY; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; T LYMPHOCYTE; TH2 CELL;

ADULT; ALLERGENS; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; MALE; NASAL MUCOSA; RHINITIS, ALLERGIC, SEASONAL; SKIN; STAT6 TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES; TH2 CELLS; YOUNG ADULT;

EID: 84865161562     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.04003.x     Document Type: Article

References (36)

1. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003; 21:713-58.
2. Ansel KM, Djuretic I, Tanasa B, Rao A. Regulation of Th2 differentiation and IL-4 locus accessibility. Annu Rev Immunol 2006; 24:607-56.
3. Hatton RD, Weaver CT. T-bet or Not T-bet. Science 2003; 302:993-4.
4. Ouyang W, Löhning M, Gao Z et al. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 2000; 12:27-37.
5. Afkarian M, Sedy JR, Yang J et al. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells. Nat Immunol 2002; 3:549-57.
6. Mullen AC, High FA, Hutchins AS et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001; 292:1907-10.
7. Finotto S, Neurath MF, Glickman JN et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002; 295:336-8.
8. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002; 295:338-42.
9. Raby BA, Hwang ES, Van Steen K et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am J Respir Crit Care Med 2006; 173:64-70.
10. Lund R, Ahlfors H, Kainonen E, Lahesmaa AM, Dixon C, Lahesmaa R. Identification of genes involved in the initiation of human Th1 or Th2 cell commitment. Eur J Immunol 2005; 35:3307-19.
11. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89:587-96.
12. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997; 272:21597-603.
13. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998; 187:939-48.
14. Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 2001; 193:1087-96.
15. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 2003; 4:78-86.
16. De Fanis U, Mori F, Kurnat RJ et al. GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood 2007; 109:4343-50.
17. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355:2226-35.
18. Shaaban R, Zureik M, Soussan D et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008; 372:1049-57.
19. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989; 6710: 1259-60.
20. Shirakawa T, Enomoto T, Shimazu S-I, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275:77-9.
21. van den Biggelaar AH, Prescott SL, Roponen M et al. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. J Allergy Clin Immunol 2009; 124:544-50.
22. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-4.
23. Taha R, Hamid Q, Cameron L, Olivenstein R. T helper type 2 cytokine receptors and associated transcription factors GATA-3, c-MAF, and signal transducer and activator of transcription factor-6 in induced sputum of atopic asthmatic patients. Chest 2003; 123:2074-82.
24. Nakamura Y, Christodoulopoulos P, Cameron L et al. Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge. J Allergy Clin Immunol 2000; 105:1146-52.
25. Banfield G, Watanabe H, Scadding G et al. CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses. Allergy 2010; 65:1126-33.
26. Nouri-Aria KT, Wachholz PA, Francis JN et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004; 172:3252-3259.
27. Nouri-Aria KT, Pilette C, Jacobson MR, Watanabe H, Durham SR. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J Allergy Clin Immunol 2005; 116:73-9.
28. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT. Grass pollen immunotherapy induces Foxp3 expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol 2008; 121: 1467-72.
29. Pulendran, B. Modulating vaccine responses with dendritic cells and Tolllike receptors. Immunol Rev 2004; 199:227-50.
30. Brightbill HD, Libraty DH, Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999; 285:732-34.
31. Mantel PY, Kuipers H, Boyman O et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 2007; 5:e329.
32. Hwang E, Szabo S, Schawrtzberg P, Glimcher L. T helper cell fate specified by kinase-mediated interaction of Tbet with GATA-3. Science 2005; 307: 430-33.
33. Ozawa H, Tamauchi H, Ito M et al. Immune responses to Nippostrongylus brasiliensis and tuberculin protein in GATA-3-transgenic mice. Immunol Lett 2005; 99:228-35.
34. Hosoya T, Maillard I, Engel JD. From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev 2010; 238:110-25.
35. Camporota L, Corkhill A, Long H et al. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur Respir J 2003; 21:287-93.
36. Creticos PS, Schroeder JT, Hamilton RG et al. Immune Tolerance Network Group. Immune tolerance network group. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis N Eng J Med 2006; 355:1445-55.